Key facts
- This page summarizes Nathan Creech's Form 4 filing for CRH PUBLIC LTD CO (CRH).
- 5 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 05 Mar 2025, 16:30.
Nathan Creech - 03 Mar 2025 Form 4 Insider Report for CRH PUBLIC LTD CO (CRH)
- Reporting relationship
- President, Americas Division
- Issuer ticker
- CRH
- Reported as of
- 03 Mar 2025
- Net transaction value
- -$2,382,585
- SEC form
- 4
- Accepted by SEC
- 05 Mar 2025, 16:30:13 UTC
- Prior SEC filing
- 02 Jan 2025
- Next SEC filing
- 15 May 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Cot Eversole, Attorney-in-Fact for Nathan Creech
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Nathan Creech filed Form 4 for CRH PUBLIC LTD CO (CRH) on 05 Mar 2025.
Change
- Previous filing in this sequence was filed on 02 Jan 2025.
- Current net transaction value: -$2,382,585.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
CRH
transaction
Ordinary Shares
Award
- Transaction value
- $0
- Shares
- +53,157
- Change %
- +84%
- Price
- $0.000000
- Shares after
- 116,323
- Date
- 03 Mar 2025
- Ownership
- Direct
- Footnotes
- F1
CRH
transaction
Ordinary Shares
Options Exercise
- Transaction value
- $0
- Shares
- +7,406
- Change %
- +6.4%
- Price
- $0.000000
- Shares after
- 123,729
- Date
- 03 Mar 2025
- Ownership
- Direct
- Footnotes
- F2
CRH
transaction
Ordinary Shares
Tax liability
- Transaction value
- $2,382,585
- Shares
- -23,833
- Change %
- -19%
- Price
- $99.97
- Shares after
- 99,896
- Date
- 03 Mar 2025
- Ownership
- Direct
- Footnotes
- F3
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
CRH
transaction
Derivative
Deferred Share Award
Options Exercise
- Transaction value
- Shares
- -6,786
- Change %
- -29%
- Price
- Shares after
- 16,529
- Date
- 03 Mar 2025
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
- 6,786
- Exercise price
- $0.000000
- Footnotes
- F2
CRH
transaction
Derivative
Deferred Share Award
Award
- Transaction value
- Shares
- +5,247
- Change %
- +32%
- Price
- Shares after
- 21,776
- Date
- 03 Mar 2025
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
- 5,247
- Exercise price
- $0.000000
- Footnotes
- F4
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 4 footnotes
Footnote F1
Reflects the vesting and release of awards granted in 2022 under the 2014 Performance Share Plan Rules on March 3, 2025 (including the award of 4,453 additional Ordinary Shares as dividend equivalents), pursuant to certification of the achievement of pre-established performance goals by the Compensation Committee of the Board of Directors of the Issuer (the "Compensation Committee").
Footnote F2
Reflects the vesting and release of a 2022 time-based conditional award as defined in the 2014 Deferred Share Bonus Plan (the "DSB Plan Rules"), of which, pursuant to the determination of the Compensation Committee, a total of 7,406 shares vested on March 3, 2025, including the award of 620 additional Ordinary Shares as dividend equivalents. Subject to the determination of the Compensation Committee, the remaining awards of 9,188 shares and 7,341 shares are expected to vest in March 2026 and March 2027, respectively. In accordance with the DSB Plan Rules, dividend equivalents will apply to these awards and, to the extent awarded, will be reported at the time of vesting.
Footnote F3
Mandatory withholding of sufficient Ordinary Shares to cover applicable tax liabilities arising in connection with the aforementioned awards.
Footnote F4
Reflects time-based conditional awards, as defined in the DSB Plan Rules, of which, subject to the determination of the Compensation Committee, the balance will vest in March 2028. In accordance with the DSB Plan Rules, dividend equivalents will apply to the Award and, to the extent awarded, will be reported at the time of vesting.